Pfizer CEO Albert Bourla in Davos, Switzerland, on May 25, 2022. Fabrice Coffrini/AFPPfizer is gearing up for a consumer-driven market for obesity drugs that could match the rapid growth it experienced after introducing erectile dysfunction drug Viagra more than 20 years ago, Chief Executive Albert Bourla said on Jan. 12.Speaking during the J.P. Morgan Healthcare Conference in San Francisco, Bourla said Pfizer underestimated how quickly patients would be willing to pay out of pocket for obesity treatments, even without insurance coverage.
22
C
Ottawa
Monday, June 8, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS